Keyphrases
Opioid Use Disorder
61%
Opioids
40%
Cigarette
36%
Oxycodone
35%
Naloxone
31%
Heroin
30%
Placebo
26%
Subjective Response
23%
Nicotine Craving
22%
Abuse Potential
21%
Abuse Liability
20%
Heroin Users
20%
People Who Use Opioids
19%
Oxycodone Self-administration
18%
Dopamine
18%
Resilience Scale
18%
Structure-property Relationships
18%
Opioid Overdose Education
18%
Lorcaserin
18%
Randomized Clinical Trial
18%
Epigenetic Aging
18%
Randomized Double-blind Placebo-controlled Study
18%
Treatment Facilities
18%
Counselors
18%
Utilization Outcomes
18%
Psychometric Properties
18%
Smoking Behavior
18%
Pioglitazone
18%
Kappa Opioid Receptor Antagonist
18%
Emotional Response
18%
Peroxisome Proliferator-activated Receptor Agonists
18%
Facility Characteristics
18%
United States
18%
Spanish Language
18%
Genetic Polymorphism
18%
Human Laboratory Models
18%
Marginal Effects
18%
Fentanyl
18%
Urine Samples
18%
Naloxone-precipitated Withdrawal
18%
Substance Use Disorder Treatment
18%
Control Analysis
18%
Subjective Effects
16%
Nicotine Withdrawal
14%
Addiction Severity Index
14%
Opioid Vaccine
12%
Extended Training
12%
Significant Others
12%
Non-hospital
11%
Substance Use Disorder
9%
Pharmacology, Toxicology and Pharmaceutical Science
Diseases
100%
Toxic Injury
52%
Naloxone
39%
Diamorphine
38%
Placebo
37%
Oxycodone
36%
Opioid Overdose
26%
Buprenorphine
24%
Cigarette Smoking
22%
Subjective Effects
19%
Buprenorphine Plus Naloxone
18%
Lorcaserin
18%
Duragesic
18%
Randomized Clinical Trial
18%
PPAR Agonist
18%
Kappa Antagonists
18%
Prevalence
18%
Pioglitazone
18%
Cannabinoid
18%
Placebo-Controlled Study
18%
Clinical Trial
12%
Clinical Study
9%
Nicotine Patch
9%
Peroxisome Proliferator Activated Receptor Gamma Agonist
9%
Randomized Controlled Trial
9%
Neuroscience
Opioid Abuse
75%
Heroin
50%
Naloxone
36%
Placebo
34%
Depression
21%
PPAR Agonist
18%
Agonist
18%
Pioglitazone
18%
Telomere
18%
Kappa Antagonists
18%
Buprenorphine
18%
Fentanyl
18%
Lorcaserin
18%
Duragesic
18%
Impulsivity
18%
Behavior (Neuroscience)
18%
Oxycodone
18%
Substance Abuse
11%
Personality Traits
8%
Anxiety Disorder
7%
Glia
6%